Hsiao-Ling Chen Selected Research

Hsiao-Ling Chen Research Topics

Disease

13	Neoplasms (Cancer) 08/2019 - 03/2008
11	Inflammation (Inflammations) 08/2021 - 04/2013
9	Body Weight (Weight, Body) 01/2018 - 02/2003
8	Fibrosis (Cirrhosis) 08/2021 - 04/2011
5	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2013
5	Lung Injury 01/2020 - 01/2011
5	Hyperoxia 01/2020 - 01/2011
4	Infections 02/2022 - 02/2008
4	Osteoporosis 11/2020 - 10/2011
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2014 - 04/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 04/2021
3	Diabetes Mellitus 04/2022 - 02/2019
3	Carcinoma (Carcinomatosis) 03/2021 - 01/2015
3	Hypertension (High Blood Pressure) 01/2021 - 10/2014
3	Atrophy 08/2020 - 01/2013
3	Stomach Neoplasms (Stomach Cancer) 01/2015 - 03/2008
3	Carcinogenesis 01/2013 - 02/2011
2	Stroke (Strokes) 04/2022 - 08/2020
2	Neoplasm Metastasis (Metastasis) 04/2021 - 08/2019
2	Squamous Cell Carcinoma of Head and Neck 08/2019 - 01/2014
2	Pneumonia (Pneumonitis) 01/2019 - 01/2013
2	Asthma (Bronchial Asthma) 01/2018 - 06/2013
2	Alzheimer Disease (Alzheimer's Disease) 05/2017 - 06/2012
2	Diarrhea 10/2014 - 01/2004
2	Respiratory Insufficiency (Respiratory Failure) 10/2014 - 01/2011
2	Adenocarcinoma of Lung 01/2014 - 01/2013
2	Muscle Spasticity (Spastic) 01/2013 - 01/2013
2	Liver Neoplasms (Liver Cancer) 01/2013 - 03/2008
2	Colonic Neoplasms (Colon Cancer) 09/2010 - 10/2007
1	Thrombosis (Thrombus) 04/2022
1	Myocardial Infarction 04/2022
1	Hemorrhage 04/2022
1	Sepsis (Septicemia) 02/2022
1	Septic Shock (Toxic Shock Syndrome) 02/2022
1	Malignant Mesothelioma 12/2021
1	Dysbiosis 08/2021
1	Cataract (Cataracts) 08/2021

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2008
9	LactoferrinIBA 01/2020 - 01/2004
6	CollagenIBA 08/2021 - 04/2011
6	AntioxidantsIBA 08/2020 - 08/2011
6	Messenger RNA (mRNA)IBA 01/2015 - 04/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2011
5	Therapeutic UsesIBA 01/2018 - 01/2011
4	(1-6)-alpha-glucomannan (glucomannan)IBA 01/2021 - 11/2006
4	Peptides (Polypeptides)IBA 08/2020 - 01/2018
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 10/2006
3	Volatile Fatty AcidsIBA 01/2021 - 09/2010
3	Inulin FDA Link 01/2021 - 10/2007
3	Superoxide DismutaseIBA 08/2020 - 01/2011
3	LuciferasesIBA 01/2020 - 10/2014
3	AllergensIBA 01/2018 - 06/2013
3	Tocopherols (Tocopherol)IBA 05/2017 - 06/2012
3	Interleukin-6 (Interleukin 6)IBA 01/2015 - 04/2013
3	CytokinesIBA 10/2014 - 01/2013
3	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2013 - 04/2011
2	Pemetrexed (MTA)FDA Link 12/2021 - 07/2003
2	PlatinumIBA 12/2021 - 12/2020
2	Anaplastic Lymphoma KinaseIBA 09/2021 - 04/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021 - 01/2013
2	MyostatinIBA 06/2019 - 02/2016
2	CreatinineIBA 02/2019 - 01/2019
2	AlbuminsIBA 01/2019 - 01/2011
2	Galactose (Galactopyranose)FDA LinkGeneric 05/2017 - 06/2012
2	Vitamin E FDA LinkGeneric 05/2017 - 03/2011
2	Botulinum Toxins (Botulinum Toxin)IBA 02/2016 - 01/2013
2	AerosolsIBA 10/2014 - 01/2011
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2014 - 01/2013
2	Cyclin BIBA 01/2013 - 01/2013
2	Cyclin AIBA 01/2013 - 01/2013
2	Glutamic Acid (Glutamate)FDA Link 08/2012 - 04/2011
2	Transaminases (Aminotransferases)IBA 08/2012 - 04/2011
2	Alanine Transaminase (SGPT)IBA 08/2012 - 04/2011
2	Oxaloacetic Acid (Oxalacetic Acid)IBA 08/2012 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 06/2012 - 01/2011
2	Bile Acids and Salts (Bile Acids)IBA 02/2011 - 09/2010
2	CelluloseIBA 09/2010 - 10/2007
2	VaccinesIBA 06/2008 - 02/2008
1	ErbB Receptors (EGF Receptor)IBA 06/2022
1	Tyrosine Kinase InhibitorsIBA 06/2022
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2022
1	thiamine triphosphorate (TTP)IBA 02/2022
1	Fibronectins (Fibronectin)IBA 08/2021
1	EndotoxinsIBA 08/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2021
1	IndicanIBA 08/2021
1	Butyric Acid (Butanoic Acid)IBA 08/2021
1	ORALIT (ORS)IBA 08/2021
1	CholesterolIBA 08/2021
1	lorlatinibIBA 04/2021
1	alectinibIBA 04/2021
1	abirateroneIBA 01/2021

Therapy/Procedure

13	Therapeutics 04/2022 - 03/2008
4	Drug Therapy (Chemotherapy) 06/2022 - 12/2020
4	Oral Administration 01/2020 - 04/2013
2	Catheters 02/2022 - 02/2019
2	Intraperitoneal Injections 01/2018 - 08/2015
1	Percutaneous Coronary Intervention 04/2022
1	Stents 04/2022
1	Salvage Therapy 12/2021